KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Co-Diagnostics (CODX) Current Taxes (2020 - 2022)

Historic Current Taxes for Co-Diagnostics (CODX) over the last 3 years, with Q1 2022 value amounting to $4.8 million.

  • Co-Diagnostics' Current Taxes rose 17426.94% to $4.8 million in Q1 2022 from the same period last year, while for Mar 2022 it was $4.8 million, marking a year-over-year increase of 17426.94%. This contributed to the annual value of $2.2 million for FY2021, which is 106644.69% up from last year.
  • Per Co-Diagnostics' latest filing, its Current Taxes stood at $4.8 million for Q1 2022, which was up 17426.94% from $2.2 million recorded in Q4 2021.
  • Co-Diagnostics' Current Taxes' 5-year high stood at $4.8 million during Q1 2022, with a 5-year trough of $47180.0 in Q2 2021.
  • In the last 3 years, Co-Diagnostics' Current Taxes had a median value of $1.4 million in 2021 and averaged $1.7 million.
  • In the last 5 years, Co-Diagnostics' Current Taxes soared by 106644.69% in 2021 and then surged by 17426.94% in 2022.
  • Over the past 3 years, Co-Diagnostics' Current Taxes (Quarter) stood at $189729.0 in 2020, then surged by 1066.45% to $2.2 million in 2021, then soared by 118.86% to $4.8 million in 2022.
  • Its Current Taxes stands at $4.8 million for Q1 2022, versus $2.2 million for Q4 2021 and $1.0 million for Q3 2021.